Status:
NOT_YET_RECRUITING
Efficacy of Acupuncture in the Treatment of Moderate-to-severe Atopic Dermatitis
Lead Sponsor:
Shanghai Yueyang Integrated Medicine Hospital
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study used a multicentre parallel three-armed randomised sham-controlled clinical trial methodology in order to objectively and normatively assess the efficacy of acupuncture on Quchi the Sea of ...
Eligibility Criteria
Inclusion
- Meet the diagnostic criteria for moderate to severe atopic dermatitis;
- Age ≥18 and ≤75 years old gender is not limited; ③ Peak Pruritus Numerical Rating Scale (PP-NRS) score ≥4; ④ Voluntarily participate in this trial and sign the informed consent form.
Exclusion
- Patients who are in the acute onset of the disease and have erosions exudates and secondary infections;
- Patients who have participated in other clinical studies in the past 3 months or are participating in other clinical studies; ③ Patients with severe haematological diseases (e.g. platelet count \<50×109 /L) and other serious diseases that may affect operation and efficacy;
- Current systematic use of glucocorticosteroids discontinued for less than 7 days; immunosuppressants (cyclosporine methotrexate tretinoin etc.) discontinued for less than 1 month; dulprevirizumab discontinued for less than 1 month JAK inhibitors discontinued for less than 2 weeks;
- Women who are pregnant or breastfeeding; ⑥ Patients with a history of acupuncture treatment.
Key Trial Info
Start Date :
April 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06922565
Start Date
April 3 2025
End Date
June 30 2026
Last Update
April 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.